XTX Topco’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12,655
| Closed | -$57.3K | – | 3268 |
|
|
2025
Q3 | $57.3K | Sell |
12,655
-17,100
| -57% | -$50.4K | ﹤0.01% | 2148 |
|
|
2025
Q2 | $64K | Buy |
+29,755
| New | +$83.2K | ﹤0.01% | 1971 |
|
|
2024
Q1 | – | Sell |
-5,110
| Closed | -$38.5K | – | 1782 |
|
|
2023
Q4 | $38.5K | Buy |
5,110
+1,444
| +39% | +$13.2K | 0.01% | 1278 |
|
|
2023
Q3 | $55K | Buy |
3,666
+2,033
| +124% | +$36.5K | 0.01% | 1267 |
|
|
2023
Q2 | $26K | Buy |
+1,633
| New | +$17.2K | ﹤0.01% | 1300 |
|
|
2022
Q4 | – | Sell |
-13,207
| Closed | -$125K | – | 1082 |
|
|
2022
Q3 | $125K | Buy |
13,207
+9,430
| +250% | +$124K | 0.03% | 903 |
|
|
2022
Q2 | $45K | Buy |
+3,777
| New | +$39.6K | 0.02% | 750 |
|
|
2022
Q1 | – | Sell |
-2,911
| Closed | -$51K | – | 641 |
|
|
2021
Q4 | $51K | Buy |
+2,911
| New | +$58.3K | 0.03% | 557 |
|
XTX Topco's ADVM Position: Q4 2025 in Review
XTX Topco sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 12,655 shares — an estimated $57.3K sold.
XTX Topco first reported a position in ADVM in Q4 2021 and held it in 8 quarters. The position peaked at $125K in Q3 2022. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- XTX Topco reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- XTX Topco sold 12,655 Adverum Biotechnologies shares in Q4 2025, an estimated $57.3K.
- XTX Topco first reported a position in Adverum Biotechnologies in Q4 2021 and held it in 8 quarters.
- XTX Topco's Adverum Biotechnologies position peaked at $125K in Q3 2022.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.